LTGOSector not reported
Latigo Biotherapeutics, Inc. (LTGO) Insider Trading
In the last 90 days, 7 Latigo Biotherapeutics, Inc. (LTGO) insiders reported 7 open-market purchases totaling $17,640,000 and no sales. The most recent open-market purchase was reported on Aug 10, 2026. Source: SEC Form 4 filings.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $17,640,000
- Corporate buyers
- 7
- Latest transaction
- Aug 10, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
Common questions
LTGO insider trading FAQ
- Are LTGO insiders buying or selling?
- Over the last 90 days, LTGO insiders were net buyers, reporting $17,640,000 of open-market purchases and $0.00 of sales.
- When was the last LTGO insider purchase?
- The most recent open-market purchase of Latigo Biotherapeutics, Inc. stock by an insider was reported on Aug 10, 2026, one of 7 purchases in the last 90 days.
- Where does LTGO insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings that Latigo Biotherapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.
